Feature | Classification | n (%) |
---|---|---|
Sex | Male | 80 (65) |
Female | 43 (35) | |
Age | ≥50 years | 116 (94.3) |
<50 years | 7 (5.7) | |
Tumor differentiation grade | Well differentiated | 37 (31.6) |
Moderately differentiated | 59 (50.4) | |
Poorly differentiated | 21 (17.9) | |
Tumor stage | I | 14 (11.5) |
II | 44 (36.1) | |
III | 49 (40.2) | |
IV | 15 (12.3) | |
Radiotherapy treatment | Did not receive radiotherapy | 96 (87.3) |
Received radiotherapy | 14 (12.7) | |
Chemotherapy treatment | Did not receive chemotherapy | 47 (38.8) |
Received chemotherapy | 74 (61.2) | |
Treatment | No chemotherapy or radiotherapy | 40 (36.4) |
Some treatment | 70 (63.6) | |
Treatment response | Response | 61 (58.1) |
No response | 44 (41.9) | |
Last follow-up status | Alive without disease | 66 (65.3) |
Alive with disease | 17 (16.8) | |
Disease progression and death | 18 (17.8) |